Navigation Links
Researchers discover how insulin-producing cells increase during pregnancy

NEW YORK, June 27, 2010 Researchers funded by JDRF have discovered that the hormone, serotonin, may be involved in the increase of insulin-producing beta cells during pregnancy. The findings reveal one of the mechanisms underlying beta cell expansion during pregnancy, and are the latest advances underscoring the potential for regeneration as a key component of a possible cure for type 1 diabetes.

The study, published online today in the journal Nature Medicine, was conducted by a team of researchers led by Dr. Michael German, Associate Director and Clinical Director of the Diabetes Center at the University of California San Francisco. The Juvenile Diabetes Research Foundation was a funder of the study.

Studying the gene expression and signaling pathways that regulate the increase of functional beta cells in pregnant mice, the researchers identified that a gene (tryptophan hydroxylase-1 or Tph1) involved in the production of serotonin is dramatically increased in beta cells of the mother during pregnancy. Serotonin is a hormone well known for its various roles in moderating behavior in animals and humans.

According to Dr. German, two pregnancy hormones (prolactin and placental lactogen) triggered the expression of the Tph1 gene in islet cells, leading to an increase in the synthesis and release of serotonin by beta cells. The released serotonin then binds to specific protein molecules (5ht2b receptors) on beta cells, which are both increased in number during pregnancy and stimulated beta-cell proliferation. At birth, the process is reversed when another form of the serotonin receptor (5ht1d) is turned on in beta cells and inhibits beta-cell proliferation, bringing the number of beta cells back down to normal non-pregnant levels. "These findings uncover a previously unknown, integrated pathway linking beta cell mass with the anticipated increase in insulin requirement during pregnancy," said Dr. German. "We are currently investigating the role of this pathway in beta cell function in pregnant women as well as working to identify targets in the pathway that could be used to come up with new drugs to promote beta cell regeneration in people with type 1 diabetes."

"This novel finding by Dr. German and his team could have tremendous implications in the potential development and use of regenerative drugs and therapies for type 1 diabetes," said Patricia Kilian, Ph.D., Program Director of Regeneration at JDRF. "It addresses a critical research goal within our Regeneration program, and we are excited to see how this will translate to humans to create applicable cure therapeutics for type 1 diabetes."

Regeneration Research

To cure people with type 1 diabetes, researchers will need to stop the autoimmune attack that causes diabetes, and restore the ability to produce insulin by either replacing or regenerating insulin producing cells.

Among the fastest-growing scientific areas JDRF supports is research aimed at regenerating insulin producing cells in people who have diabetes. This involves triggering the body to grow its own beta cells, either by copying existing ones - some are usually still active, even in people who have had diabetes for decades - or inducing the pancreas to create new ones.


Contact: Joana Casas
Juvenile Diabetes Research Foundation International

Related biology news :

1. Researchers develop accurate way to predict the age when women will hit the menopause
2. Researchers discover source of essential nutrients for mid-ocean algae
3. Researchers at UH work to prevent neurological diseases
4. Researchers create self-assembling nanodevices that move and change shape on demand
5. UCI researchers develop worlds first plastic antibodies
6. Little is understood about alcohols effect on fetal development, Georgetown researchers say
7. Researchers identify a fundamental process in lysosomal function and protein degradation
8. High-yield agriculture slows pace of global warming, say Stanford researchers
9. Mass. General researchers develop functional, transplantable rat liver grafts
10. OU researchers find way to prevent blindness in research model for retinitis pigmentosa
11. Texas A&M veterinary researchers achieve cloning first
Post Your Comments:
(Date:6/9/2016)... an innovation leader in attendance control systems is proud to announce the introduction of ... make sure the right employees are actually signing in, and to even control the ... ... ... ...
(Date:6/7/2016)... , June 7, 2016  Syngrafii Inc. ... a business relationship that includes integrating Syngrafii,s patented ... branch project. This collaboration will result in greater ... the credit union, while maintaining existing document workflow ... ...
(Date:6/2/2016)... June 2, 2016 The Department of ... awarded the 44 million US Dollar project, for the ... Plates including Personalization, Enrolment, and IT Infrastructure , ... the production and implementation of Identity Management Solutions. Numerous renowned ... Decatur was selected for the most ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... Hill, N.C. (PRWEB) , ... June 27, 2016 ... ... U.S. commercial operations for Amgen, will join the faculty of the University ... serve as adjunct professor of strategy and entrepreneurship at UNC Kenan-Flagler, with a ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial ... Cary 5000 and the 6000i models are higher end machines that use the more ... the spectrophotometer’s light beam from the bottom of the cuvette holder. , FireflySci ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
(Date:6/23/2016)... -- The Biodesign Challenge (BDC), a university competition that asks ... systems and biotechnology, announced its winning teams at the ... York City . The teams, chosen ... MoMA,s Celeste Bartos Theater during the daylong summit. Keynote ... of architecture and design, and Suzanne Lee , ...
Breaking Biology Technology: